You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Biosimilar infliximab: short-term efficacy and safety following switch from originator
- In: Oral presentation on Tuesday, 12 September 2017, 14:30-17:30
- At: Seoul (South Korea) (2017)
- Type: Presentation
- By: MATULUKO, Ayodeji (University College London, School of Pharmacy, London, UK)
- Co-author(s): Ayodeji Benedicta Matuluko: School of Pharmacy, University College London, United Kingdom
Natalie Bidad: Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
Scott Mercer: Immunotherapy (Rheumatology, Dermatology, Allergy), Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom - Abstract:
Methods
A retrospective/prospective evaluation with a convenience sample of 28 adults who had switched from originator to biosimilar infliximab, was conducted in a rheumatology clinic in London, United Kingdom. Data from patients’ records was collected from May to July 2016, including demographic characteristics, markers of clinical response and
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026